Organogenesis Holdings ORGO spent $270K on lobbying in Q2 2024 · Medicare, Health Issues

Trade details

Type: Lobbying report
Amount: $270,000
Quarter: Q2 2024
Stock: Organogenesis Holdings ORGO
Client: Organogenesis
Reported: 24/07/17

Up 17.4% from last quarter

What else happened in Organogenesis Holdings around then

Filed or reported within 30 days of the trade day · 24/05/31~24/07/30

Organogenesis's other lobbying reports

Organogenesis
LobbyingOrganogenesis Holdings
Lobbying
Organogenesis Holdings
ORGO
$33.7K
$33.7K
Reported 07/20
for Q2
Organogenesis
LobbyingOrganogenesis Holdings
Lobbying
Organogenesis Holdings
ORGO
$80K
$80K
Reported 07/18
for Q2
Organogenesis
LobbyingOrganogenesis Holdings
Lobbying
Organogenesis Holdings
ORGO
$15K
$15K
Reported 07/03
for Q2
Organogenesis
LobbyingOrganogenesis Holdings
Lobbying
Organogenesis Holdings
ORGO
$14K
$14K
Reported 04/20
for Q1
Organogenesis
LobbyingOrganogenesis Holdings
Lobbying
Organogenesis Holdings
ORGO
$20K
$20K
Reported 04/16
for Q1